Drugmakers 'inching ahead' in increasing access to drugs worldwide, with GlaxoSmithKline leading the pack

Nicole refers to the eight pharmaceutical companies that integrate access planning into their pipeline, noting that 12 companies are still lagging behind and most of the key products are not supported by access plans.

The article dives deeper into the findings on the various health products assessed by the Index with a focus on the related access strategies. It also gives a brief overview of the companies implementing such strategies in low- and middle-income countries.

Read the full article here.